Rosuvastatin-Induced Rhabdomyolysis - Possible Role of Ticagrelor and Patients’ Pharmacogenetic Profile

Basic and Clinical Pharmacology and Toxicology - United States
doi 10.1111/bcpt.13035
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Rosuvastatin (Crestor) and Rhabdomyolysis

CMAJ
Medicine
2004English

Phenytoin-Induced Rhabdomyolysis

Journal of Case Reports in Medicine
2015English

Severe Rosuvastatin Accumulation With Rhabdomyolysis Due to Drug Interactions and Low Cardiac Output Syndrome

British Journal of Clinical Pharmacology
Pharmacology
2019English

Malignant Drug-Induced Rhabdomyolysis

Journal of Nephropathology
Nephrology
2012English

The Role of Ticagrelor in STEMI Fibrinolytic and Its Rationale to Utilize for Indonesian Patients

Indonesian Journal of Cardiology
2019English

Heparin Induced Thrombocytopenia in Patients With Severe Rhabdomyolysis: A Case Series

Pathology
Forensic MedicinePathology
2020English

Ticagrelor-Induced Angioedema: A Rare and Unexpected Phenomenon

Case Reports in Cardiology
Cardiovascular MedicineCardiology
2017English

Role of Warfarin Pharmacogenetic Testing in Clinical Practice

Pharmacogenomics
Molecular MedicineGeneticsPharmacology
2010English

Anaesthesia Induced Rhabdomyolysis a Case Report

Canadian Journal of Anaesthesia
MedicineAnesthesiologyPain Medicine
1983English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy